fficacy and Safety of Bosutinib Vs Imatinib By Charlson Comorbidity Index in Newly Diagnosed Patients with Chronic Myeloid Leukemia

被引：0
|
作者：
Deininger, Michael W. [1 ]
Brummendorf, Tim H. [2 ,3 ]
Lipton, Jeffrey H. [4 ]
Milojkovic, Dragana [5 ]
Stenke, Leif [6 ,7 ]
Leip, Eric [9 ]
Purcell, Simon [8 ,10 ]
Viqueira, Andrea [11 ]
Cortes, Jorge E. [12 ]
机构：
[1] Univ Utah, Huntsman Canc Inst, Div Hematol & Hematol Malignancies, Salt Lake City, UT USA
[2] Univ Med Ctr Aachen, Dept Internal Med 4, Aachen, Germany
[3] Univ Klinikum RWTH Aachen, Med Klin 4, Aachen, Germany
[4] Princess Margaret Canc Ctr, Hans Messner Allogene Blood & Marrow Transplant U, Toronto, ON, Canada
[5] Imperial Coll NHS Trust, Hammersmith Hosp, Dept Haematol, London, England
[6] Karolinska Univ Hosp, Dept Hematol, Theme Canc, Stockholm, Sweden
[7] Karolinska Univ Hosp, Dept Med Solna, Stockholm, Sweden
[8] Karolinska Inst, Stockholm, Sweden
[9] Pfizer Inc, Cambridge, MA USA
[10] Pfizer Ltd, London, England
[11] Pfizer SLU, Madrid, Spain
[12] Augusta Univ, Georgia Canc Ctr, Augusta, GA USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-163276
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3913 / 3915
页数：3
相关论文
共 50 条
  • [31] Efficacy and Tolerability of Bosutinib and Imatinib in Older Versus Younger Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia-BELA Trial
    Gambacorti-Passerini, Carlo
    Bruemmendorf, Tim H.
    Kim, Dong-Wook
    Dyagil, Irina
    Kantarjian, Hagop M.
    Pavlov, Dmitri
    Gogat, Karin
    Duvillie, Ladan
    Shapiro, Mark
    Cortes, Jorge E.
    BLOOD, 2012, 120 (21)
  • [32] An Ongoing Phase 3 Study of Bosutinib (SKI-606) Versus Imatinib In Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
    Gambacorti-Passerini, Carlo
    Kim, Dong-Wook
    Kantarjian, Hagop M.
    Brummendorf, Tim H.
    Dyagil, Irina
    Griskevicius, Laimonas
    Malhotra, Hemant
    Goh, Yeow-Tee
    Wang, Junyuan
    Gogat, Karin
    Cortes, Jorge
    BLOOD, 2010, 116 (21) : 95 - 96
  • [33] Phase 2 Study of Bosutinib in Japanese Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
    Takahashi, Naoto
    Matsumura, Itaru
    Fujisawa, Shin
    Ishizawa, Kenichi
    Ono, Takaaki
    Sakaida, Emiko
    Sekiguchi, Naohiro
    Tanetsugu, Yusuke
    Fukuhara, Kei
    Ohkura, Masayuki
    Koide, Yuichiro
    Hino, Masayuki
    BLOOD, 2019, 134
  • [34] Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia
    Masayuki Hino
    Itaru Matsumura
    Shin Fujisawa
    Kenichi Ishizawa
    Takaaki Ono
    Emiko Sakaida
    Naohiro Sekiguchi
    Yusuke Tanetsugu
    Kei Fukuhara
    Masayuki Ohkura
    Yuichiro Koide
    Naoto Takahashi
    International Journal of Hematology, 2020, 112 : 24 - 32
  • [35] Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia
    Hino, Masayuki
    Matsumura, Itaru
    Fujisawa, Shin
    Ishizawa, Kenichi
    Ono, Takaaki
    Sakaida, Emiko
    Sekiguchi, Naohiro
    Tanetsugu, Yusuke
    Fukuhara, Kei
    Ohkura, Masayuki
    Koide, Yuichiro
    Takahashi, Naoto
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (01) : 24 - 32
  • [36] Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
    Saglio, Giuseppe
    Kim, Dong-Wook
    Issaragrisil, Surapol
    le Coutre, Philipp
    Etienne, Gabriel
    Lobo, Clarisse
    Pasquini, Ricardo
    Clark, Richard E.
    Hochhaus, Andreas
    Hughes, Timothy P.
    Gallagher, Neil
    Hoenekopp, Albert
    Dong, Mei
    Haque, Ariful
    Larson, Richard A.
    Kantarjian, Hagop M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (24): : 2251 - 2259
  • [37] Imatinib superior to interferon for newly diagnosed chronic myeloid leukemia
    不详
    FORMULARY, 2003, 38 (01) : 17 - +
  • [38] BOSUTINIB VERSUS IMATINIB IN NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA: 30-MONTH UPDATE OF THE BELA TRIAL
    Brummendorf, T.
    Gambacorti-Passerini, C.
    Lipton, J.
    Tee, G. Y.
    Casado, L. F.
    Zaritskey, A.
    Le Coutre, P.
    Duvillie, L.
    Gogat, K.
    Pavlov, D.
    Countouriotis, A.
    Byrne, J.
    HAEMATOLOGICA, 2012, 97 : 239 - 240
  • [39] Comparable Efficacy and Safety of Chinese Generic Imatinib and Branded Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia: A Retrospective Study
    Dou, Xuelin
    Qin, Yazhen
    Lai, Yueyun
    Shi, Hongxia
    Huang, Xiaojun
    Jiang, Qian
    BLOOD, 2019, 134
  • [40] Imatinib mesylate in newly diagnosed patients of chronic myeloid leukemia chronic phase: A comparative study
    Jacob, L. A.
    Bapsy, P. P.
    Govindbabu, K.
    Lokanatha, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345